Form 4: ImmunityBio CFO David Sachs Reports Stock Transactions
SEC Form 4
David Sachs, CFO of ImmunityBio, reports the vesting and disposal of restricted stock units and common stock on December 31, 2024.
Summary
- On December 31, 2024, David Sachs, the Chief Financial Officer of ImmunityBio, Inc. [IBRX], reported transactions involving the company's stock.
- These transactions included the vesting of 30,397 restricted stock units (RSUs) which converted into common stock.
- Sachs also disposed of 15,405 shares of common stock at a price of $2.56 per share to cover tax obligations.
- Following these transactions, Sachs directly owns 200,830 shares of ImmunityBio common stock and 75,999 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to investors regarding the actions of company executives.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they represent a small percentage of the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 12/09/2021 | 17,242 of the RSUs vested |
| 09/09/2021 | Five percent (5%) of the remaining 151,989 RSUs (rounded down to the nearest whole share) vested |
| 12/31/2022 | Five percent (5%) of the RSUs (rounded down to the nearest whole share) vested |
| 12/31/2023 | Twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested |
| 12/31/2024 | Transaction Date: Vesting of RSUs and disposal of shares; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested |
| 12/31/2025 | Twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest |
| 12/31/2026 | Remaining RSUs will vest |
| 01/03/2025 | Date of signature by Attorney-in-Fact |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.